Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: IM Epinephrine for Pediatric Out-of-Hospital Cardiac Arrest
NCT05166343Phase 3Recruiting
- Start
- Jan 2024
- Primary completion
- Jan 2028
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epinephrine in cardiac arrest (SCA). Started Jan 2024; status: recruiting.
02
Drugs
epinephrine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT05166343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05166343.